New Jersey A1207 mandates Medicaid coverage for ovulation enhancing drugs and related medical services for beneficiaries aged 21-44 experiencing.
New Jersey A1207 requires Medicaid to cover ovulation enhancing drugs and medical services for beneficiaries aged 21-44 experiencing infertility. The bill defines infertility as the inability to conceive after 12 months of regular, unprotected intercourse for those aged 21-34, and six months for those aged 35-44. Covered medical services include office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing. Treatment is limited to three cycles per lifetime.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.